Word: non-hodgkin
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...That is not to say Thompson hasn't had to overcome many personal hardships - a marriage while in high school after conceiving a child with his teenage girlfriend, a subsequent divorce, a diagnosis of non-Hodgkin's lymphoma 2 1/2 years ago and, perhaps most traumatic, the sudden death of his daughter Betsy in 2002 from an accidental overdose of prescription drugs. He is now married to a Republican political strategist and has two small children...
DIED. GEORGE ARCHER, 65, towering golf champ known for his exacting putting stroke; of Burkitt's lymphoma, a rare form of non-Hodgkin's lymphoma; at his home in Incline Village, Nev. Though the 6-ft. 5-in. Archer tried to follow his father's advice to pursue basketball--"where the hole is way up there," as the son recalled him saying--he went on to win 12 P.G.A. championships, including the 1969 Masters, and 19 events on the 50-and-older Champions Tour...
...early-stage drug-discovery firm. "There's a lot of concern about losing your money." Mullen's focus on diverse products, production synergies and profitability is already part of the culture at top industry players Amgen and Genentech. Biogen's Avonex for multiple sclerosis and IDEC's Rituxan for non-Hodgkin's lymphoma each generate more than $1 billion in annual sales, and both companies are solidly profitable. Yet "the combination will create more value than either could as separate entities," says William Rastetter, ceo of IDEC. That's why a wave of mergers could sweep the industry. There...
...doesn't take a rocket scientist to figure out this is junk science. School officials dispute the numbers Brockovich is throwing about. They say 216 claims have been filed against the school district, and only 94 of them involve cancers. And what about those specific cancers - Hodgkin's Lymphoma, non-Hodgkin's Lymphoma and thyroid cancer - listed in the initial suit filed against the oil companies by the Brockovich firm? As the University of Southern California medical school's Cancer Surveillance Program flatly states, "Known causes of these cancers are not petroleum or petroleum products...
...synergies and profitability at the proposed Biogen IDEC, where he would be CEO, is already part of the culture at top industry players Amgen and Genentech. So he's got a blueprint--and a lot to work with. Biogen's Avonex for multiple sclerosis and IDEC's Rituxan for non-Hodgkin's lymphoma each generate more than $1 billion in annual sales, and both companies are solidly profitable. Yet "the combination will create more value than either could as separate entities," says William Rastetter, CEO of IDEC, who would get the title of executive chairman after the merger. The focus...